S-1

You have access
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer
TSUTOMU TAKASHIMA, SHIGEHIKO NISHIMURA, HIDEMI KAWAJIRI, YOKO MIZUYAMA, TAKEO NISHIMORI, SHIGEHITO YAMAGATA, SHINYA TOKUNAGA, KENJI TEZUKA, SEIKA TEI, TAKESHI SUNAMI, KATSUMI IKEDA, YOSHINARI OGAWA, SHINICHIRO KASHIWAGI, SATORU NODA, NAOYOSHI ONODA, TETSURO ISHIKAWA, SHINZOH KUDOH, MINORU TAKADA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research October 2021, 41 (10) 5007-5014; DOI: https://doi.org/10.21873/anticanres.15315
You have access
Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1
SHINSUKE HATORI, KENTARO SAKAMAKI, TAKEHIKO YOKOHORI, YAYOI KIMURA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, KEISUKE KOMORI, HAYATO WATANABE, KAZUKI KANO, HIROHITO FUJIKAWA, TORU AOYAMA, MASAKATSU NUMATA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, MANABU SHIZAWA, NORIO YUKAWA, SOICHIRO MORINAGA, YASUSHI RINO, MUNETAKA MASUDA, HIROSHI SAEKI, YOHEI MIYAGI and TAKASHI OSHIMA

Anticancer Research July 2021, 41 (7) 3583-3588; DOI: https://doi.org/10.21873/anticanres.15146
You have access
Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13)
MAYUKO MIKI, SHINTARO TAKAO, MUNEHARU KONISHI, YASUSHI SHIGEOKA, MASARU MIYASHITA, HIROFUMI SUWA, YASUO MIYOSHI, KOICHI HIROKAGA, TOSHITAKA OKUNO, KAZUHIKO YAMAGAMI, MICHIKO IMAMURA, KEIKO MURASE, AYAKO YANAI and HIROKAZU TANINO

Anticancer Research June 2021, 41 (6) 3121-3126; DOI: https://doi.org/10.21873/anticanres.15096
You have access
Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma
SHOZO MORI, TAKU AOKI, YUHKI SAKURAOKA, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUKIHIRO ISO and KEIICHI KUBOTA

Anticancer Research March 2021, 41 (3) 1629-1639; DOI: https://doi.org/10.21873/anticanres.14925
You have access
Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin
EO JIN KIM, MOONHO KIM, SEYOUNG SEO, MI-JUNG KIM, MIN JU KIM and SOOK RYUN PARK

Anticancer Research January 2021, 41 (1) 391-402; DOI: https://doi.org/10.21873/anticanres.14788
You have access
Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative Surgery
ITARU HASHIMOTO, NAOHIDE OUE, YAYOI KIMURA, YUKIHIKO HIROSHIMA, KENTARO HARA, YUKIO MAEZAWA, KAZUKI KANO, HIROHITO FUJIKAWA, TORU AOYAMA, MASAKATSU NUMATA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, MANABU SHIOZAWA, SOICHIRO MORINAGA, YASUSHI RINO, WATARU YASUI, MUNETAKA MASUDA, YOHEI MIYAGI and TAKASHI OSHIMA

Anticancer Research October 2020, 40 (10) 5815-5821; DOI: https://doi.org/10.21873/anticanres.14599
You have access
Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer
TOSHIHIRO TANAKA, MAKI TANAKA, HIDEMI FURUSAWA, YOSHIHIKO KAMADA, YOSHIAKI SAGARA, KEISEI ANAN, KYUICHIROU MIYARA, YUICHIROU KAI, TATSUYA UGA, KAZUO TAMURA, SHOSHU MITSUYAMA and KBC-SG (Kyushu Breast Cancer-Study Group)

Anticancer Research August 2020, 40 (8) 4779-4785; DOI: https://doi.org/10.21873/anticanres.14480
You have access
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy
MASATAKA ONEYAMA, NAOYA SAKAMOTO, NAOHIDE OUE, YAYOI KIMURA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, KENTARO HARA, YUKIO MAEZAWA, KAZUKI KANO, TORU AOYAMA, HIROHITO FUJIKAWA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, HARUHIKO CHO, HIROYUKI ITO, NORIO YUKAWA, MANABU SHIOZAWA, TAKAKI YOSHIKAWA, SOICHIRO MORINAGA, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI, WATARU YASUI and TAKASHI OSHIMA

Anticancer Research December 2019, 39 (12) 6567-6573; DOI: https://doi.org/10.21873/anticanres.13872
You have access
In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells
YORIHISA MORO, YASUNAO KOGASHIWA, HIROYUKI SAKURAI, RYO TAKAHASHI, TORU KIMURA, MASATAKA HIRASAKI, YOSHIFUMI MATSUMOTO, MASASHI SUGASAWA and NAOYUKI KOHNO

Anticancer Research November 2019, 39 (11) 6041-6047; DOI: https://doi.org/10.21873/anticanres.13810
You have access
S-1 Monotherapy After Failure of Platinum Plus 5-Fluorouracil Chemotherapy in Recurrent or Metastatic Esophageal Carcinoma
TAKAHIKO ITO, YOSHITAKA HONMA, HIDEKAZU HIRANO, HIROKAZU SHOJI, NATSUKO OKITA, SATORU IWASA, ATSUO TAKASHIMA, KEN KATO and NARIKAZU BOKU

Anticancer Research July 2019, 39 (7) 3931-3936; DOI: https://doi.org/10.21873/anticanres.13545

Main menu

User menu

Search

S-1

Pages